The Immune Checkpoint Modulator OX40 and Its Ligand OX40L in NK-Cell Immunosurveillance and Acute Myeloid Leukemia.
Nuebling T, Schumacher CE, Hofmann M, Hagelstein I, Schmiedel BJ, Maurer S, Federmann B, Rothfelder K, Roerden M, Dörfel D, Schneider P, Jung G, Salih HR.
Nuebling T, et al.
Cancer Immunol Res. 2018 Feb;6(2):209-221. doi: 10.1158/2326-6066.CIR-17-0212. Epub 2018 Jan 10.
Cancer Immunol Res. 2018.
PMID: 29321210